San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story and see what’s trending.
San Diego company says offer undervalues the company; updates progress on novel pain management therapies […]
LA JOLLA, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has rece… […]
LA JOLLA—Salk Professor Kay Tye has been recognized for her contributions and dedication to advancing science through research by being named to the Wylie Vale Chair.
The post Salk professor Kay Tye honored with endowed chair appeared first on Salk Ins… […]
San Diego-based Sorrento Therapeutics isn’t going the M&A route — at least not today.
The biotech caused quite a stir when it put out word a few weeks ago that an unidentified private equity group was bidding a billion dollars-plus for the company…. […]
San Diego-based Sorrento Therapeutics isn’t going the M&A route — at least not today.
The biotech caused quite a stir when it put out word a few weeks ago that an unidentified private equity group was bidding a billion dollars-plus for the company…. […]
NEW YORK–(BUSINESS WIRE)–Opentrons Labworks, Inc. (“Opentrons”) and Swift Biosciences, Inc. (“Swift”) announce the launch of the most affordable fully-automated workstation for next-generation sequencing (NGS) library preparation ever put on the mark… […]
– All patients showed tumor regression by radiographic scan at 8 weeks and confirmation by further tumor shrinkage at 16 weeks; clinical benefit achieved in 100% (n=5) of patients- Tumor regression occurred across all major KRAS mutation types in CRC, … […]
While experts say Truvian is well prepared to meet accuracy and precision targets on its machines, it hasn’t proven its devices work yet […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
